[Federal Register Volume 77, Number 89 (Tuesday, May 8, 2012)]
[Pages 27065-27066]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-11096]



Centers for Disease Control and Prevention


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-7570 or send an email to 
omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-5806. 
Written comments should be received within 30 days of this notice.

Proposed Project

    National Adult Tobacco Survey (NATS)--Reinstatement with Changes--
National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), Centers for Disease Control and Prevention (CDC) and the 
Center for Tobacco Products (CTP), Food and Drug Administration (FDA).

Background and Brief Description

    Tobacco use remains the leading preventable cause of disease and 
death in the United States, resulting in approximately 440,000 deaths 
annually. Smokers die an average of 14 years earlier than nonsmokers. 
Moreover, cigarette smoking costs more than $193 billion; $97 billion 
in lost productivity plus $96 billion in health care expenditures.
    With passage of the Family Smoking Prevention and Tobacco Control 
Act (Tobacco Control Act) in 2009, the FDA is legally mandated to 
regulate tobacco products for the protection of public health. Such 
authority involves considering whether the marketing of tobacco 
products might encourage people who don't use tobacco products to begin 
using them, to encourage people who might otherwise quit to continue 
using tobacco, or to encourage former users to relapse.
    In order to ensure that FDA is in compliance with the Tobacco 
Control Act's mandate to protect the public health, annual data 
collection is needed at least initially to monitor the benefits and 
potential adverse consequences of FDA's regulatory actions, as the 
regulatory framework is being established. As novel tobacco products 
are introduced onto the market, the FDA must regularly monitor patterns 
of all tobacco product usage--not just cigarettes--to identify changes 
in susceptibility and rates of tobacco use initiation, perceptions 
regarding tobacco use, and rates of tobacco use cessation.
    Rather than develop a completely new system to monitor measures 
critical to FDA, and thereby increasing burden to the population, FDA 
has partnered with CDC to leverage the existing NATS system. While NATS 
has been re-designed to meet the critical data needs of the FDA, many 
of the measures are relevant to CDC's National Tobacco Control Program 
(NTCP), and CDC also will use the NATS data to evaluate the NTCP. Many 
of the NATS questions reflect CDC's key outcome indicators for 
evaluating tobacco control programs.
    CDC proposes to conduct three annual cycles of the NATS to collect 
data necessary to evaluate the effectiveness of FDA's initial 
regulatory actions. The NATS will be a stratified, random-digit dialed 
telephone survey of non-institutionalized adults 18 years of age and 
older. To yield results that are representative nationally, information 
will be collected from 56,250 landline respondents and 18,750 cell 
phone respondents who do not have a landline to include the growing 
population of households that exclusively use cell phones and would be 
missed in a survey relying only on land-lines. To obtain the target 
number of completed telephone interviews, approximately 166,000 
respondents will be contacted for initial eligibility screening and 
    The burden per response for the proposed NATS remains the same by 
design as the 2009/2010 NATS. However, the number of respondents is 
smaller because the current NATS seeks to develop national estimates, 
whereas the 2009/2010 NATS sought to develop state-level estimates. 
Therefore, the total respondent burden for the new NATS cycle is 
substantially lower than the prior NATS. The 2009/2010 NATS involved a 
total respondent burden of 38,303 hours. The revised 2012/2013 NATS 
involves a total respondent burden of 29,850 hours, which amounts to 
8,453 fewer hours, or 22.1% fewer hours, than the 2009/2010 NATS.
    Results will have significant implications for the development and 
periodic adjustment of policies and programs aimed at preventing and 
reducing tobacco use in the United States.
    Participation in the NATS is voluntary. There are no costs to 
respondents except their time. The total estimated annualized burden 
hours are 29,850.

[[Page 27066]]

                                        Estimated Annualized Burden Hours
                                                                     Number of       Number of      burden per
         Type of respondent                   Form name             respondents    responses per   response (in
                                                                                    respondent        hours)
Adults ages 18 or older............  Screener for land-line              125,000               1            2/60
                                      users (pp. 3-8 of the
                                     Screener for cell phone              41,000               1            1/60
                                      users (pp. 9-11 of the
                                     National Adult Tobacco               56,250               1           20/60
                                      Survey for landline users
                                      (pp. 12-end of the NATS).
                                     National Adult Tobacco               18,750               1           20/60
                                      Survey for cell phone
                                      users (pp. 12-end of the

Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity, Office of the 
Associate Director for Science, Office of the Director, Centers for 
Disease Control and Prevention.
[FR Doc. 2012-11096 Filed 5-7-12; 8:45 am]